AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED

Hyderabad-based Aizant Drug Research Solutions has generated a revenue figure of Rs 144 crore during the FY19-20, exhibiting a decline of 5 per cent in its business when compared to the revenue generation of Rs 151 crore in the previous fiscal. Aizant is a rapidly growing contract research organisation with a diverse portfolio of capabilities, partnering with health care companies specialising in new molecular entities (NMEs), generics (ANDAs) and over the counter (OTCs) products globally. It offers comprehensive solutions for preformulation, formulation development of conventional and novel drug delivery products, bioavailability, bioequivalence, bioanalysis, pharmacokinetics, biostatistics and clinical diagnostics.